Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene.

BACKGROUND The human mitochondrial trifunctional protein (MTP) complex is composed of 4 hydroacyl-CoA dehydrogenase-alpha (HADHA) and 4 hydroacyl-CoA dehydrogenase-beta (HADHB) subunits, which catalyze the last 3 steps in the fatty acid beta-oxidation spiral of long-chain fatty acids. The HADHB gene encodes long-chain ketoacyl-CoA thiolase (LCTH) activity, whereas the HADHA gene contains the information for the long-chain enoyl-CoA hydratase and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) functions. At present, 2 different biochemical phenotypes of defects in the mitochondrial trifunctional protein complex are known: isolated LCHAD deficiency and generalized MTP deficiency, with decreased activities of all 3 enzymes. Isolated LCTH deficiency with mutations in the HADHB gene has not been reported. PATIENT AND RESULTS We report a male newborn who presented with lactic acidosis, pulmonary edema, and cardiomyopathy leading to acute heart failure and death at the age of 6 weeks. Routine newborn screening by tandem mass spectrometry showed increased concentrations of the acylcarnitines tetradecenoylcarnitine, hexadecenoylcarnitine, hydroxypalmitoylcarnitine, and hydroxyoctadecenoylcarnitine, suggesting LCHAD deficiency or complete MTP deficiency. Enzyme investigations revealed very low LCTH (4% of normal) and normal LCHAD activities, whereas molecular analysis showed compound heterozygosity for 185G > A (R62H) and 1292T > C (F431S) mutations in the HADHB gene. CONCLUSION We describe the first case of isolated LCTH deficiency based on a mutation in the HADHB gene.

[1]  R. Wanders,et al.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. , 2002, Pediatrics.

[2]  R. Wanders,et al.  Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. , 1996, The Journal of clinical investigation.

[3]  T. Aoyama,et al.  Structural analysis of cDNAs for subunits of human mitochondrial fatty acid beta-oxidation trifunctional protein. , 1994, Biochemical and biophysical research communications.

[4]  D. Turnbull,et al.  Trifunctional enzyme deficiency: Adult presentation of a usually fatal β‐oxidation defect , 1996, Annals of neurology.

[5]  M. Bennett,et al.  Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency. , 1995, The Journal of clinical investigation.

[6]  J. Haines,et al.  Uniparental disomy of chromosome 2 resulting in lethal trifunctional protein deficiency due to homozygous α‐subunit mutations , 2002, Human mutation.

[7]  P. Vreken,et al.  Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects , 1999, Journal of Inherited Metabolic Disease.

[8]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[9]  A. Munnich,et al.  Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. , 1992, Biochemical and biophysical research communications.

[10]  H. Heng,et al.  The Genes for the α and β Subunits of the Mitochondrial Trifunctional Protein Are Both Located in the Same Region of Human Chromosome 2p23 , 1996 .

[11]  J. Ibdah,et al.  A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. , 1999, The New England journal of medicine.

[12]  R. Wanders,et al.  Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype-phenotype correlation. , 1998, The Journal of clinical investigation.

[13]  Dörte Stephan,et al.  Long-chain-3-hydroxyacyl-CoA dehydrogenase , 1995 .

[14]  M. Bennett,et al.  General Mitochondrial Trifunctional Protein (TFP) Deficiency as a Result of Either α- or β-Subunit Mutations Exhibits Similar Phenotypes Because Mutations in Either Subunit Alter TFP Complex Expression and Subunit Turnover , 2004, Pediatric Research.

[15]  T. Aoyama,et al.  Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits. , 1996, American journal of human genetics.

[16]  J. Isaacs,et al.  Maternal Acute Fatty Liver of Pregnancy Associated with Fetal Trifunctional Protein Deficiency: Molecular Characterization of a Novel Maternal Mutant Allele , 1996, Pediatric Research.

[17]  N. Lehman,et al.  Early neonatal diagnosis of long-chain 3-hydroxyacyl coenzyme a dehydrogenase and mitochondrial trifunctional protein deficiencies. , 2002, Molecular genetics and metabolism.

[18]  M. Bennett,et al.  Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to β‐subunit mutations , 2003 .

[19]  D. Rabier,et al.  Recognition and management of fatty acid oxidation defects: A series of 107 patients , 1999, Journal of Inherited Metabolic Disease.

[20]  R. Wanders,et al.  Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. , 2003, The Journal of pediatrics.

[21]  E. Mayatepek,et al.  Diagnosis of Mitochondrial Trifunctional Protein Deficiency in a Blood Spot from the Newborn Screening Card by Tandem Mass Spectrometry and DNA Analysis , 1999, Pediatric Research.

[22]  R. Wanders,et al.  Neonatal screening for defects of the mitochondrial trifunctional protein. , 2005, Molecular genetics and metabolism.

[23]  H. Kubo.  gene a , 1997 .

[24]  R. Wanders,et al.  Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. , 1999, Clinica chimica acta; international journal of clinical chemistry.